FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113169146> ?p ?o ?g. }

• W2113169146 endingPage "802" @default.
• W2113169146 startingPage "5796" @default.
• W2113169146 abstract "Because the apoptotic pathway is often disrupted in tumor cells, its genetic restoration is a very attractive approach for the treatment of tumors. To treat malignant gliomas with this approach, it would be preferred to restrict induction of apoptosis to tumor cells by establishing a tumor-specific expression system. Telomerase is an attractive target because the vast majority of malignant gliomas have telomerase activity whereas normal brain cells do not. Activation of telomerase is tightly regulated at the transcriptional level of the telomerase catalytic subunit [human telomerase reverse transcriptase, (hTERT)]. Therefore, we hypothesized that using a hTERT promoter-driven vector system, an apoptosis-inducible gene may be preferentially restricted to telomerase- or hTERT-positive tumor cells. In this study, we constructed an expression vector consisting of the constitutively active caspase-6 (rev-caspase-6) under the hTERT promoter (hTERT/rev-caspase-6) and then investigated its antitumor effect on malignant glioma cells. The rationale for using the rev-caspase-6 gene is because it induces apoptosis independent of the initiator caspases. We demonstrated that the hTERT/rev-caspase-6 construct induced apoptosis in hTERT-positive malignant glioma cells, but not in hTERT-negative astrocytes, fibroblasts, and alternative lengthening of telomeres cells. In addition, the growth of s.c. tumors in nude mice was significantly suppressed by the treatment with hTERT/rev-caspase-6 construct. The present results strongly suggest that the telomerase-specific transfer of the rev-caspase-6 gene under the hTERT promoter is a novel targeting approach for the treatment of malignant gliomas." @default.
• W2113169146 created "2016-06-24" @default.
• W2113169146 creator A5001331102 @default.
• W2113169146 creator A5007764464 @default.
• W2113169146 creator A5013468113 @default.
• W2113169146 creator A5016395681 @default.
• W2113169146 creator A5019747361 @default.
• W2113169146 creator A5024037872 @default.
• W2113169146 creator A5036467815 @default.
• W2113169146 creator A5040125343 @default.
• W2113169146 creator A5060565773 @default.
• W2113169146 creator A5061032146 @default.
• W2113169146 creator A5077708146 @default.
• W2113169146 creator A5079412406 @default.
• W2113169146 creator A5081012778 @default.
• W2113169146 creator A5082807098 @default.
• W2113169146 creator A5087927550 @default.
• W2113169146 date "2001-08-01" @default.
• W2113169146 modified "2023-10-16" @default.
• W2113169146 title "Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter." @default.
• W2113169146 cites W1496772673 @default.
• W2113169146 cites W1533906146 @default.
• W2113169146 cites W1589415602 @default.
• W2113169146 cites W1672932778 @default.
• W2113169146 cites W1775874584 @default.
• W2113169146 cites W1919304720 @default.
• W2113169146 cites W1964228845 @default.
• W2113169146 cites W1977907679 @default.
• W2113169146 cites W1978438689 @default.
• W2113169146 cites W1981106016 @default.
• W2113169146 cites W1984374449 @default.
• W2113169146 cites W1989113088 @default.
• W2113169146 cites W1991865867 @default.
• W2113169146 cites W1995541635 @default.
• W2113169146 cites W2000971601 @default.
• W2113169146 cites W2002503549 @default.
• W2113169146 cites W2007613355 @default.
• W2113169146 cites W2013618157 @default.
• W2113169146 cites W2022507419 @default.
• W2113169146 cites W2026856852 @default.
• W2113169146 cites W2033107803 @default.
• W2113169146 cites W2036594498 @default.
• W2113169146 cites W2049462421 @default.
• W2113169146 cites W2070580563 @default.
• W2113169146 cites W2074452470 @default.
• W2113169146 cites W2079378073 @default.
• W2113169146 cites W2091289442 @default.
• W2113169146 cites W2093419093 @default.
• W2113169146 cites W2098619352 @default.
• W2113169146 cites W2108344049 @default.
• W2113169146 cites W2108967610 @default.
• W2113169146 cites W2111440980 @default.
• W2113169146 cites W2113300169 @default.
• W2113169146 cites W2115346781 @default.
• W2113169146 cites W2118228848 @default.
• W2113169146 cites W2123111989 @default.
• W2113169146 cites W2126224474 @default.
• W2113169146 cites W2139360111 @default.
• W2113169146 cites W2142089788 @default.
• W2113169146 cites W2150110662 @default.
• W2113169146 cites W2151495730 @default.
• W2113169146 cites W2315482376 @default.
• W2113169146 cites W2315523562 @default.
• W2113169146 cites W2328197645 @default.
• W2113169146 cites W2099106106 @default.
• W2113169146 cites W2105871477 @default.
• W2113169146 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11479218" @default.
• W2113169146 hasPublicationYear "2001" @default.
• W2113169146 type Work @default.
• W2113169146 sameAs 2113169146 @default.
• W2113169146 citedByCount "44" @default.
• W2113169146 countsByYear W21131691462012 @default.
• W2113169146 countsByYear W21131691462013 @default.
• W2113169146 countsByYear W21131691462014 @default.
• W2113169146 countsByYear W21131691462016 @default.
• W2113169146 countsByYear W21131691462018 @default.
• W2113169146 countsByYear W21131691462022 @default.
• W2113169146 crossrefType "journal-article" @default.
• W2113169146 hasAuthorship W2113169146A5001331102 @default.
• W2113169146 hasAuthorship W2113169146A5007764464 @default.
• W2113169146 hasAuthorship W2113169146A5013468113 @default.
• W2113169146 hasAuthorship W2113169146A5016395681 @default.
• W2113169146 hasAuthorship W2113169146A5019747361 @default.
• W2113169146 hasAuthorship W2113169146A5024037872 @default.
• W2113169146 hasAuthorship W2113169146A5036467815 @default.
• W2113169146 hasAuthorship W2113169146A5040125343 @default.
• W2113169146 hasAuthorship W2113169146A5060565773 @default.
• W2113169146 hasAuthorship W2113169146A5061032146 @default.
• W2113169146 hasAuthorship W2113169146A5077708146 @default.
• W2113169146 hasAuthorship W2113169146A5079412406 @default.
• W2113169146 hasAuthorship W2113169146A5081012778 @default.
• W2113169146 hasAuthorship W2113169146A5082807098 @default.
• W2113169146 hasAuthorship W2113169146A5087927550 @default.
• W2113169146 hasConcept C104292427 @default.
• W2113169146 hasConcept C104317684 @default.
• W2113169146 hasConcept C125593758 @default.
• W2113169146 hasConcept C153911025 @default.
• W2113169146 hasConcept C177336024 @default.

• next